You are here: Home / Fat Loss Tips / Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer

September 26, 2019By
Please share...Share on Google+Tweet about this on TwitterShare on StumbleUponShare on Facebook

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer. Pegilodecakin with pembrolizumab and nivolumab shown to be safe in Phase 1B study.
Latest Science News — ScienceDaily

Filed Under: Fat Loss Tips Tagged With: , , , , , , , , , , ,